Follicular Lymphoma Drugs Market - Global Outlook and Forecast 2023-2027

Report ID: 685007 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Follicular Lymphoma Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Follicular Lymphoma Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Follicular Lymphoma Drugs Overall Market Size
    2.1 Global Follicular Lymphoma Drugs Market Size: 2021 VS 2027
    2.2 Global Follicular Lymphoma Drugs Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Follicular Lymphoma Drugs Players in Global Market
    3.2 Top Global Follicular Lymphoma Drugs Companies Ranked by Revenue
    3.3 Global Follicular Lymphoma Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Follicular Lymphoma Drugs Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Follicular Lymphoma Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Follicular Lymphoma Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Follicular Lymphoma Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Follicular Lymphoma Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Follicular Lymphoma Drugs Market Size Markets, 2021 & 2027
        4.1.2 Chemotherapy Drug
        4.1.3 Monoclonal Antibody
        4.1.4 Kinase Inhibitor
        4.1.5 CAR T-cell Therapy
        4.1.6 Others
    4.2 By Type - Global Follicular Lymphoma Drugs Revenue & Forecasts
        4.2.1 By Type - Global Follicular Lymphoma Drugs Revenue, 2016-2021
        4.2.2 By Type - Global Follicular Lymphoma Drugs Revenue, 2022-2027
        4.2.3 By Type - Global Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Follicular Lymphoma Drugs Market Size, 2021 & 2027
        5.1.2 < 55
        5.1.3 55-64
        5.1.4 65+
    5.2 By Application - Global Follicular Lymphoma Drugs Revenue & Forecasts
        5.2.1 By Application - Global Follicular Lymphoma Drugs Revenue, 2016-2021
        5.2.2 By Application - Global Follicular Lymphoma Drugs Revenue, 2022-2027
        5.2.3 By Application - Global Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Follicular Lymphoma Drugs Market Size, 2021 & 2027
    6.2 By Region - Global Follicular Lymphoma Drugs Revenue & Forecasts
        6.2.1 By Region - Global Follicular Lymphoma Drugs Revenue, 2016-2021
        6.2.2 By Region - Global Follicular Lymphoma Drugs Revenue, 2022-2027
        6.2.3 By Region - Global Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Follicular Lymphoma Drugs Revenue, 2016-2027
        6.3.2 US Follicular Lymphoma Drugs Market Size, 2016-2027
        6.3.3 Canada Follicular Lymphoma Drugs Market Size, 2016-2027
        6.3.4 Mexico Follicular Lymphoma Drugs Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Follicular Lymphoma Drugs Revenue, 2016-2027
        6.4.2 Germany Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.3 France Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.4 U.K. Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.5 Italy Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.6 Russia Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.7 Nordic Countries Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.8 Benelux Follicular Lymphoma Drugs Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Follicular Lymphoma Drugs Revenue, 2016-2027
        6.5.2 China Follicular Lymphoma Drugs Market Size, 2016-2027
        6.5.3 Japan Follicular Lymphoma Drugs Market Size, 2016-2027
        6.5.4 South Korea Follicular Lymphoma Drugs Market Size, 2016-2027
        6.5.5 Southeast Asia Follicular Lymphoma Drugs Market Size, 2016-2027
        6.5.6 India Follicular Lymphoma Drugs Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Follicular Lymphoma Drugs Revenue, 2016-2027
        6.6.2 Brazil Follicular Lymphoma Drugs Market Size, 2016-2027
        6.6.3 Argentina Follicular Lymphoma Drugs Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Follicular Lymphoma Drugs Revenue, 2016-2027
        6.7.2 Turkey Follicular Lymphoma Drugs Market Size, 2016-2027
        6.7.3 Israel Follicular Lymphoma Drugs Market Size, 2016-2027
        6.7.4 Saudi Arabia Follicular Lymphoma Drugs Market Size, 2016-2027
        6.7.5 UAE Follicular Lymphoma Drugs Market Size, 2016-2027
7 Players Profiles
    7.1 Genentech (Roche)
        7.1.1 Genentech (Roche) Corporate Summary
        7.1.2 Genentech (Roche) Business Overview
        7.1.3 Genentech (Roche) Follicular Lymphoma Drugs Major Product Offerings
        7.1.4 Genentech (Roche) Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.1.5 Genentech (Roche) Key News
    7.2 Bristol-Myers Squibb
        7.2.1 Bristol-Myers Squibb Corporate Summary
        7.2.2 Bristol-Myers Squibb Business Overview
        7.2.3 Bristol-Myers Squibb Follicular Lymphoma Drugs Major Product Offerings
        7.2.4 Bristol-Myers Squibb Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.2.5 Bristol-Myers Squibb Key News
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Corporate Summary
        7.3.2 Gilead Sciences Business Overview
        7.3.3 Gilead Sciences Follicular Lymphoma Drugs Major Product Offerings
        7.3.4 Gilead Sciences Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.3.5 Gilead Sciences Key News
    7.4 TG Therapeutics
        7.4.1 TG Therapeutics Corporate Summary
        7.4.2 TG Therapeutics Business Overview
        7.4.3 TG Therapeutics Follicular Lymphoma Drugs Major Product Offerings
        7.4.4 TG Therapeutics Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.4.5 TG Therapeutics Key News
    7.5 Bayer
        7.5.1 Bayer Corporate Summary
        7.5.2 Bayer Business Overview
        7.5.3 Bayer Follicular Lymphoma Drugs Major Product Offerings
        7.5.4 Bayer Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.5.5 Bayer Key News
    7.6 Secura Bio
        7.6.1 Secura Bio Corporate Summary
        7.6.2 Secura Bio Business Overview
        7.6.3 Secura Bio Follicular Lymphoma Drugs Major Product Offerings
        7.6.4 Secura Bio Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.6.5 Secura Bio Key News
    7.7 Epizyme
        7.7.1 Epizyme Corporate Summary
        7.7.2 Epizyme Business Overview
        7.7.3 Epizyme Follicular Lymphoma Drugs Major Product Offerings
        7.4.4 Epizyme Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.7.5 Epizyme Key News
    7.8 Jazz Pharmaceuticals
        7.8.1 Jazz Pharmaceuticals Corporate Summary
        7.8.2 Jazz Pharmaceuticals Business Overview
        7.8.3 Jazz Pharmaceuticals Follicular Lymphoma Drugs Major Product Offerings
        7.8.4 Jazz Pharmaceuticals Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.8.5 Jazz Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Follicular Lymphoma Drugs Market Opportunities & Trends in Global Market
    Table 2. Follicular Lymphoma Drugs Market Drivers in Global Market
    Table 3. Follicular Lymphoma Drugs Market Restraints in Global Market
    Table 4. Key Players of Follicular Lymphoma Drugs in Global Market
    Table 5. Top Follicular Lymphoma Drugs Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global Follicular Lymphoma Drugs Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global Follicular Lymphoma Drugs Revenue Share by Companies, 2016-2021
    Table 8. Global Companies Follicular Lymphoma Drugs Product Type
    Table 9. List of Global Tier 1 Follicular Lymphoma Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Follicular Lymphoma Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Follicular Lymphoma Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Follicular Lymphoma Drugs Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - Follicular Lymphoma Drugs Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global Follicular Lymphoma Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - Follicular Lymphoma Drugs Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - Follicular Lymphoma Drugs Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global Follicular Lymphoma Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global Follicular Lymphoma Drugs Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global Follicular Lymphoma Drugs Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America Follicular Lymphoma Drugs Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe Follicular Lymphoma Drugs Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia Follicular Lymphoma Drugs Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America Follicular Lymphoma Drugs Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa Follicular Lymphoma Drugs Revenue, (US$, Mn), 2022-2027
    Table 30. Genentech (Roche) Corporate Summary
    Table 31. Genentech (Roche) Follicular Lymphoma Drugs Product Offerings
    Table 32. Genentech (Roche) Follicular Lymphoma Drugs Revenue (US$, Mn), (2016-2021)
    Table 33. Bristol-Myers Squibb Corporate Summary
    Table 34. Bristol-Myers Squibb Follicular Lymphoma Drugs Product Offerings
    Table 35. Bristol-Myers Squibb Follicular Lymphoma Drugs Revenue (US$, Mn), (2016-2021)
    Table 36. Gilead Sciences Corporate Summary
    Table 37. Gilead Sciences Follicular Lymphoma Drugs Product Offerings
    Table 38. Gilead Sciences Follicular Lymphoma Drugs Revenue (US$, Mn), (2016-2021)
    Table 39. TG Therapeutics Corporate Summary
    Table 40. TG Therapeutics Follicular Lymphoma Drugs Product Offerings
    Table 41. TG Therapeutics Follicular Lymphoma Drugs Revenue (US$, Mn), (2016-2021)
    Table 42. Bayer Corporate Summary
    Table 43. Bayer Follicular Lymphoma Drugs Product Offerings
    Table 44. Bayer Follicular Lymphoma Drugs Revenue (US$, Mn), (2016-2021)
    Table 45. Secura Bio Corporate Summary
    Table 46. Secura Bio Follicular Lymphoma Drugs Product Offerings
    Table 47. Secura Bio Follicular Lymphoma Drugs Revenue (US$, Mn), (2016-2021)
    Table 48. Epizyme Corporate Summary
    Table 49. Epizyme Follicular Lymphoma Drugs Product Offerings
    Table 50. Epizyme Follicular Lymphoma Drugs Revenue (US$, Mn), (2016-2021)
    Table 51. Jazz Pharmaceuticals Corporate Summary
    Table 52. Jazz Pharmaceuticals Follicular Lymphoma Drugs Product Offerings
    Table 53. Jazz Pharmaceuticals Follicular Lymphoma Drugs Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. Follicular Lymphoma Drugs Segment by Type
    Figure 2. Follicular Lymphoma Drugs Segment by Application
    Figure 3. Global Follicular Lymphoma Drugs Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Follicular Lymphoma Drugs Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Follicular Lymphoma Drugs Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Follicular Lymphoma Drugs Revenue in 2020
    Figure 8. By Type - Global Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
    Figure 9. By Application - Global Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
    Figure 10. By Region - Global Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
    Figure 11. By Country - North America Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
    Figure 12. US Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
    Figure 16. Germany Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 17. France Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
    Figure 24. China Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 28. India Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
    Figure 30. Brazil Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
    Figure 33. Turkey Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE Follicular Lymphoma Drugs Revenue, (US$, Mn), 2016-2027
    Figure 37. Genentech (Roche) Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Bristol-Myers Squibb Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. Gilead Sciences Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. TG Therapeutics Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. Bayer Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Secura Bio Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 43. Epizyme Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 44. Jazz Pharmaceuticals Follicular Lymphoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Follicular Lymphoma Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Follicular Lymphoma Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Follicular Lymphoma Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports